Transaction · 0002123975-26-000008

Sahin Ugur

Sahin Ugur, CEO, reported an open-market or private sale at BioNTech SE involving 45000.000000 shares for an estimated $4628232.00. Reported holdings after the transaction were 813209.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCEO

BNTXBioNTech SE

Filing timeSep 08

Trade dateSep 03, 2026

Filing · SECView on SEC

InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows

Price at filing

—

Pre-filing

1mo ago1w ago1d ago

Returns since

7d30d90d180d1y

BNTX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards

BNTX since 2026-09-08Filed yesterday · 1 day of post-filing data

Loading…

Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative

Type: Sell
Identifier: 0002123975-26-000008
Transaction date: Sep 03, 2026
Shares: 45.0k sh
Estimated value: -$462M
Holdings after: 813k sh

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M

Direct Ownership Large Sale 10b5-1 Detected

-4score

Filing-only score

-4

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Executive Officer

Officer YesDirector No10% YesOther No

Footnotes & amended

No footnotes recorded.

Original filing · 0002123975-26-000008

Related transactions

0 other filings

Same reporting owner

Recent company activity

0 recent txs

BNTX